Lugano Financial Advisors SA (LFA)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-112
Closed -$3.12K 175
2023
Q3
$3.12K Buy
+112
New +$3.66K ﹤0.01% 173

Other funds holding ARKG

Lugano Financial Advisors SA (LFA)'s ARKG Position: Q4 2023 in Review

Lugano Financial Advisors SA (LFA) sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 112 shares — an estimated $3.12K sold.

Lugano Financial Advisors SA (LFA) first reported a position in ARKG in Q3 2023 and held it in 1 quarter. The position peaked at $3.12K in Q3 2023. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Lugano Financial Advisors SA (LFA) reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Lugano Financial Advisors SA (LFA) sold 112 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $3.12K.
  • Lugano Financial Advisors SA (LFA) first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 1 quarter.
  • Lugano Financial Advisors SA (LFA)'s ARK Genomic Revolution ETF position peaked at $3.12K in Q3 2023.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q4 2023, filed 22 Jan 2024.